Origen de la red de primer grado Richard Riese.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 61 | |
| Public Company | Pharmaceuticals: Major | 21 | |
| Public Company | Biotechnology | 13 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Richard Riese a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| ALLOVIR, INC. | Biotechnology | President Chairman Corporate Officer/Principal General Counsel Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Sales & Marketing Human Resources Officer Corporate Officer/Principal Corporate Officer/Principal Compliance Officer | |
| ABEONA THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
| SPRINGWORKS THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| KYMERA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
| Yale University | College/University | Corporate Officer/Principal Graduate Degree Doctorate Degree | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Graduate Degree Graduate Degree | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ARIAD PHARMACEUTICALS, INC. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| SCHOLAR ROCK HOLDING CORPORATION | Biotechnology | Chairman Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| ARVINAS, INC. | Biotechnology | Director/Board Member General Counsel Corporate Officer/Principal | |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Director/Board Member | |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Digi-Key Corp. distributes electronic components. It also distributes semiconductors, discrete, electromechanical parts. Its products include audio products, batteries, cable assemblies, capacitors, computer & video accessories, connectors, crystals & oscillators, discrete semiconductor products and many more. The company was founded by Ronald A. Stordahl in 1972 and is headquartered in Thief River Falls, MN. | College/University | Graduate Degree Doctorate Degree Doctorate Degree | |
| KARYOPHARM THERAPEUTICS INC. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Compliance Officer | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Human Resources Officer Corporate Officer/Principal General Counsel | |
| Princeton University | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| DYNE THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
| University of Connecticut | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
SpringWorks Therapeutics LLC
 SpringWorks Therapeutics LLC BiotechnologyHealth Technology SpringWorks Therapeutics, Inc. engages in the development of biopharmaceutical products for patients with severe rare diseases and cancer. It focuses in advancing the pipeline of standalone and combination therapies with an initial focus on rare diseases and oncology. The company was founded by Lara S. Sullivan in 2017 and is headquartered in Stamford, CT. | Biotechnology | Director/Board Member Chief Executive Officer | |
| INTELLIA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
| PDL BIOPHARMA, INC. | Biotechnology | Director/Board Member Chairman | |
| BIOHAVEN LTD. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
NMD Pharma A/S
 NMD Pharma A/S BiotechnologyHealth Technology NMD Pharma ApS engages with the research and preparation of small molecules targeting an undisclosed ion. It offers medical treatment of neuromuscular diseases for patients with chronic muscle wasting diseases such as myasthenia gravis and amyotrophic lateral sclerosis. The company was founded by Ole B?kgaard Nielsen, Thomas Holm Pedersen, and Claus Elsborg Olesen on May 7, 2015 and is headquartered in Aarhus, Denmark. | Biotechnology | Chairman Director/Board Member | |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| Worcester Polytechnic Institute | College/University | Chairman Undergraduate Degree | |
| SYROS PHARMACEUTICALS, INC. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
| Indiana University | College/University | Doctorate Degree Undergraduate Degree | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| SAREPTA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Sales & Marketing Human Resources Officer | |
| University of Bristol | College/University | Doctorate Degree Undergraduate Degree | |
LifeEDIT Therapeutics, Inc.
 LifeEDIT Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of ElevateBio LLC, LifeEDIT Therapeutics, Inc. is a next-generation genome editing company that has built a highly innovative platform with one of the world's largest and most diverse collections of novel RNA-guided nucleases (RGNs) and base editors. The company offers gene editing tools with higher fidelity, novel functionality, reduced immune response risk, and easier delivery. LifeEDIT has a large and diverse library of RGNs, including type II and type V systems that encompass knock-out and knock-in capabilities, transcriptional regulation, and base editing when coupled with one of their proprietary deaminases. The company's nuclease collection has a broad range of protospacer adjacent motifs (PAMs), offering unprecedented access to genomes. LifeEDIT is headquartered in Morrisville, NC. The CEO of the company is Mitchell H. Finer. LifeEDIT Therapeutics was acquired by ElevateBio LLC from AgBiome Delta LLC on October 27, 2021. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Doctorate Degree | |
| PASSAGE BIO, INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
ElevateBio LLC
 ElevateBio LLC BiotechnologyHealth Technology ElevateBio LLC is a biotechnology holding company, which creates and operates a broad portfolio of cell and gene therapy companies. It builds single and multi-product companies by providing scientific founders with bench-to-bedside capabilities including scientists, manufacturing facilities, drug developers, and commercial expertise. The company was founded by David L. Hallal, Vikas Sinha, and Mitchell H. Finer and is headquartered in Cambridge, MA. | Biotechnology | Founder Chief Executive Officer | |
VectivBio AG
 VectivBio AG BiotechnologyHealth Technology VectivBio AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli in 2019 and is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Gemini Therapeutics Sub, Inc.
 Gemini Therapeutics Sub, Inc. BiotechnologyHealth Technology Gemini Therapeutics Sub, Inc. engages in the development of treatments for age-related macular degeneration (AMD) and linked ocular disorders. Its multimodal pipeline includes monoclonal antibodies, recombinant proteins and gene therapies. The company was founded by James McLaughlin, Johanna Seddon, Paul Barlow and Andrew Herbert in 2015 and is headquartered in Cambridge, MA. | Biotechnology | Chairman Chief Executive Officer | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| CHEMOMAB THERAPEUTICS LTD. | Biotechnology | Chairman Director/Board Member | |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor Private Equity Investor | |
Gennao Bio, Inc.
 Gennao Bio, Inc. Pharmaceuticals: MajorHealth Technology Gennao Bio, Inc. is a privately-held genetic medicines company that is developing first-in-class, non-viral, targeted nucleic acid therapeutics utilizing its proprietary gene monoclonal antibody (gmab) platform technology. The company is based in Pennington, NJ. The company's gmab technology uses a novel, cell-penetrating antibody to non-covalently bind to, and deliver therapeutic levels of a wide variety of nucleic acid payloads, to select cells. Gennao Bio is initially focusing on addressing significant unmet needs in oncology and rare monogenic skeletal muscle diseases. The company's non-viral delivery platform offers significant advantages over traditional gene delivery systems as it can deliver multiple types of nucleic acids, allows for repeat dosing and dose optimization, and can be easily and affordably manufactured. The company was founded in 2020 by Bruce Turner, Elias Quijano, Peter M. Glazer, Stephen P. Squinto. Christopher M. Duke has been the CEO of the company since 2021. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| Washington University in St. Louis | College/University | Graduate Degree Director/Board Member | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Graduate Degree Corporate Officer/Principal |
Estadísticas
Internacional
| Estados Unidos | 47 |
| Dinamarca | 2 |
| Reino Unido | 2 |
| Suiza | 2 |
| Israel | 2 |
Sectorial
| Health Technology | 36 |
| Consumer Services | 13 |
| Health Services | 2 |
| Commercial Services | 2 |
| Finance | 2 |
Operativa
| Director/Board Member | 373 |
| Corporate Officer/Principal | 254 |
| Independent Dir/Board Member | 143 |
| Undergraduate Degree | 80 |
| Chairman | 71 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Michael Powell | 48 |
| Stephen P. Squinto | 40 |
| Chau Khuong | 38 |
| John Clarke | 30 |
| Felix Baker | 28 |
| Max E. Link | 28 |
| William Keller | 26 |
| Michael Heffernan | 23 |
| M. Burns | 23 |
| Christopher Coughlin | 23 |
| Margaret Hamburg | 22 |
| Dave Anderson | 21 |
| David Brennan | 19 |
| Kevin Starr | 19 |
| Warren W. Wasiewski | 19 |
- Bolsa de valores
- Insiders
- Richard Riese
- Conexiones Empresas
